It is common for BRAF mutations, especially BRAF V600E mutation, to be correlated with MSI in advanced colorectal cancer [32, 36, 37], which may be related to CpG island methylator phenotype and hypermethylation of MLH1 promoter [38]. The gene discussed is BRAF; the disease is colorectal cancer.